drug toxicity Videos
-
Nanoassemblr Blaze mRNA Vaccine Demo - Video
Blaze Brings the Power to Scale A candidate drug must be shown to be both potent and non-toxic in relevant models. While early early screening in murine models is enough to begin a program, the demands for data from larger models is increasing. Traditionally, process development for nanomedicine production at an intermediate scale is a barrier to this work. However, with NxGen technology on the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you